| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PLIANT THERAPEUTICS, INC. | Director | Common Stock (Right to Buy) | 30K | $55.7K | $2.08 | Jun 5, 2025 | Direct |
| Marker Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 137K | Nov 17, 2025 | Direct | ||
| Korro Bio, Inc. | Director | Stock Option (Right to Buy) | 6.01K | Jun 11, 2025 | Direct | ||
| ARENA PHARMACEUTICALS INC | Director | Common Stock | 0 | $98.51 | Mar 11, 2022 | Direct | |
| ARENA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | Mar 11, 2022 | Direct |